— Know what they know.
Not Investment Advice

QTNT NASDAQ

Quotient Limited
1W: +79.1% 1M: -50.0% 3M: -93.7% 1Y: -99.6% 3Y: -99.9% 5Y: -99.8%
$0.38
Last traded 2022-12-30 — delisted
NASDAQ · Healthcare · Medical - Devices

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$39M -11.2% ▼
5Y CAGR: +11.6%
Gross Profit
$15M -35.9% ▼
5Y CAGR: +5.6%
Operating Income
-$92M -11.8% ▼
Net Income
-$125M -15.4% ▼
EPS (Diluted)
$-49.11 -3.7% ▼
EBITDA
-$85M -17.8% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$25M$29M$33M$43M$39M
YoY Growth+11.3%+17.8%+12.1%+32.8%-11.2%
Cost of Revenue$10M$17M$18M$20M$24M
Gross Profit$14M$12M$15M$23M$15M
Gross Margin57.7%40.9%45.5%53.7%38.8%
R&D Expenses$51M$51M$54M$54M$59M
SG&A Expenses$33M$40M$42M$52M$60M
Operating Expenses$84M$91M$96M$106M$119M
Operating Income-$70M-$79M-$81M-$83M-$92M
Operating Margin-283.0%-271.0%-247.1%-190.2%-239.4%
Interest Expense$15M$20M$24M$26M$32M
Income Before Tax-$83M-$105M-$102M-$107M-$124M
Tax Expense-$649K$44K$661K$2M$961K
Net Income-$82M-$105M-$103M-$108M-$125M
Net Margin-332.9%-361.7%-314.7%-250.1%-324.9%
EPS (Diluted)$-80.65$-76.82$-57.41$-47.35$-49.11
EBITDA-$57M-$95M-$90M-$97M-$85M
Shares Outstanding1M1M2M2M3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms